Annual Cash & Cash Equivalents
$121.63 M
-$50.52 M-29.35%
31 December 2023
Summary:
Dyne Therapeutics annual cash & cash equivalents is currently $121.63 million, with the most recent change of -$50.52 million (-29.35%) on 31 December 2023. During the last 3 years, it has fallen by -$179.23 million (-59.57%). DYN annual cash & cash equivalents is now -59.57% below its all-time high of $300.85 million, reached on 31 December 2020.DYN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$532.16 M
-$76.03 M-12.50%
30 September 2024
Summary:
Dyne Therapeutics quarterly cash and cash equivalents is currently $532.16 million, with the most recent change of -$76.03 million (-12.50%) on 30 September 2024. Over the past year, it has increased by +$401.88 million (+308.48%). DYN quarterly cash and cash equivalents is now -12.50% below its all-time high of $608.20 million, reached on 30 June 2024.DYN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DYN Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.4% | +308.5% |
| 3 y3 years | -59.6% | +132.3% |
| 5 y5 years | +1397.1% | - |
DYN Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -59.6% | at low | -12.5% | +337.5% |
| 5 y | 5 years | -59.6% | +1397.1% | -12.5% | +3537.0% |
| alltime | all time | -59.6% | +1397.1% | -12.5% | +3537.0% |
Dyne Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $532.16 M(-12.5%) |
| June 2024 | - | $608.20 M(+123.6%) |
| Mar 2024 | - | $272.04 M(+123.7%) |
| Dec 2023 | $121.63 M(-29.3%) | $121.63 M(-6.6%) |
| Sept 2023 | - | $130.28 M(-22.3%) |
| June 2023 | - | $167.61 M(-7.5%) |
| Mar 2023 | - | $181.11 M(+5.2%) |
| Dec 2022 | $172.15 M | $172.15 M(+18.8%) |
| Sept 2022 | - | $144.90 M(+6.6%) |
| June 2022 | - | $135.98 M(-8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $147.97 M(-26.3%) |
| Dec 2021 | $200.82 M(-33.2%) | $200.82 M(-12.3%) |
| Sept 2021 | - | $229.04 M(-11.4%) |
| June 2021 | - | $258.38 M(-16.9%) |
| Mar 2021 | - | $310.95 M(+3.4%) |
| Dec 2020 | $300.85 M(+1956.1%) | $300.85 M(-20.7%) |
| Sept 2020 | - | $379.61 M(+162.0%) |
| June 2020 | - | $144.87 M(+890.1%) |
| Dec 2019 | $14.63 M(+80.1%) | $14.63 M |
| Dec 2018 | $8.12 M | - |
FAQ
- What is Dyne Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Dyne Therapeutics?
- What is Dyne Therapeutics annual cash & cash equivalents year-on-year change?
- What is Dyne Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Dyne Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of DYN is $121.63 M
What is the all time high annual cash & cash equivalents for Dyne Therapeutics?
Dyne Therapeutics all-time high annual cash & cash equivalents is $300.85 M
What is Dyne Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, DYN annual cash & cash equivalents has changed by -$50.52 M (-29.35%)
What is Dyne Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of DYN is $532.16 M
What is the all time high quarterly cash and cash equivalents for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly cash and cash equivalents is $608.20 M
What is Dyne Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, DYN quarterly cash and cash equivalents has changed by +$401.88 M (+308.48%)